This company is no longer active
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
InDex Pharmaceuticals Holding Gestion
Gestion contrôle des critères 2/4
InDex Pharmaceuticals Holding's CEO is Jenny Sundqvist, appointed in Jan 2023, has a tenure of 1.42 years. total yearly compensation is SEK3.54M, comprised of 64% salary and 36% bonuses, including company stock and options. directly owns 0.023% of the company’s shares, worth SEK65.60K. The average tenure of the management team and the board of directors is 4.6 years and 8.4 years respectively.
Informations clés
Jenny Sundqvist
Directeur général
SEK 3.5m
Rémunération totale
Pourcentage du salaire du PDG | 64.0% |
Durée du mandat du directeur général | 1.4yrs |
Propriété du PDG | 0.02% |
Durée moyenne d'occupation des postes de direction | 4.6yrs |
Durée moyenne du mandat des membres du conseil d'administration | 8.4yrs |
Mises à jour récentes de la gestion
Recent updates
Market Might Still Lack Some Conviction On InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Even After 35% Share Price Boost
Jun 13Further Upside For InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Shares Could Introduce Price Risks After 26% Bounce
Apr 28We're Keeping An Eye On InDex Pharmaceuticals Holding's (STO:INDEX) Cash Burn Rate
Jul 11We Think InDex Pharmaceuticals Holding (STO:INDEX) Can Afford To Drive Business Growth
Jan 21We Think InDex Pharmaceuticals Holding (STO:INDEX) Can Afford To Drive Business Growth
Aug 31Here's Why We're Watching InDex Pharmaceuticals Holding's (STO:INDEX) Cash Burn Situation
Mar 29InDex Pharmaceuticals Holding's (STO:INDEX) Shareholders Are Down 24% On Their Investment Over The Past Year.
Feb 04How Much Are InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Insiders Spending On Buying Shares?
Dec 21Analyse de la rémunération des PDG
Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
---|---|---|---|
Mar 31 2024 | n/a | n/a | -SEK 56m |
Dec 31 2023 | SEK 4m | SEK 2m | -SEK 95m |
Rémunération vs marché: Jenny's total compensation ($USD338.03K) is above average for companies of similar size in the Swedish market ($USD256.68K).
Rémunération et revenus: Insufficient data to compare Jenny's compensation with company performance.
PDG
Jenny Sundqvist (53 yo)
1.4yrs
Titularisation
SEK 3,543,000
Compensation
Ms. Jenny Sundqvist serves as Chief Executive Officer of InDex Pharmaceuticals Holding AB (publ) since January 01, 2023. She served as Chief Commercial Officer of Isofol Medical AB (publ) from January 1, 2...
Équipe de direction
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
Chief Executive Officer | 1.4yrs | SEK 3.54m | 0.023% SEK 65.6k | |
Deputy CEO & Chief Financial Officer | 7.1yrs | SEK 2.80m | 0.073% SEK 209.8k | |
Chief Scientific Officer | 2.1yrs | pas de données | 0.0017% SEK 4.9k | |
Head of Regulatory Affairs | 11.4yrs | pas de données | pas de données |
4.6yrs
Durée moyenne de l'emploi
56yo
Âge moyen
Gestion expérimentée: INDEX's management team is considered experienced (4.6 years average tenure).
Membres du conseil d'administration
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
Independent Director | 13.4yrs | SEK 235.00k | 0.081% SEK 232.4k | |
Independent Director | 8.4yrs | SEK 235.00k | 0.077% SEK 219.5k | |
Director | less than a year | pas de données | pas de données | |
Member of Advisory Board - North America | no data | pas de données | pas de données | |
Member of Advisory Board - Europe | no data | pas de données | pas de données | |
Independent Chairman | 13.4yrs | SEK 500.00k | 0.14% SEK 406.6k | |
Member of Advisory Board - Europe | no data | pas de données | pas de données | |
Chairman of Advisory Board - Europe | 2yrs | pas de données | pas de données | |
Member of Advisory Board - Europe | no data | pas de données | pas de données | |
Member of Advisory Board - Europe | no data | pas de données | pas de données | |
Member of Advisory Board - Europe | no data | pas de données | pas de données | |
Member of Advisory Board - North America | no data | pas de données | pas de données |
8.4yrs
Durée moyenne de l'emploi
70yo
Âge moyen
Conseil d'administration expérimenté: INDEX's board of directors are considered experienced (8.4 years average tenure).